Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy: Special Session

In-vivo proliferation imaging for early response assessment in patients with aggressive non-Hodgkins lymphoma

Ken Herrmann, Ivan Santi, Ulrich Keller, Tibor Schuster, Martina Rudelius, Hans-Jürgen Wester, Christian Peschel, Markus Schwaiger, Tobias Dechow and Andreas Buck
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 32;
Ken Herrmann
1Nuclear Medicine, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivan Santi
1Nuclear Medicine, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrich Keller
2Hematology and Oncology, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tibor Schuster
3Medical Statistics, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Rudelius
4Pathology, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans-Jürgen Wester
1Nuclear Medicine, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Peschel
2Hematology and Oncology, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Schwaiger
1Nuclear Medicine, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Dechow
2Hematology and Oncology, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Buck
1Nuclear Medicine, TU München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 52 no. supplement 1 32

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2011

Author Information

  1. Ken Herrmann1,
  2. Ivan Santi1,
  3. Ulrich Keller2,
  4. Tibor Schuster3,
  5. Martina Rudelius4,
  6. Hans-Jürgen Wester1,
  7. Christian Peschel2,
  8. Markus Schwaiger1,
  9. Tobias Dechow2 and
  10. Andreas Buck1
  1. 1Nuclear Medicine, TU München, Munich, Germany
  2. 2Hematology and Oncology, TU München, Munich, Germany
  3. 3Medical Statistics, TU München, Munich, Germany
  4. 4Pathology, TU München, Munich, Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014200
Dec 2014200
Jan 2015100
Mar 2015200
Jun 2015300
Jul 2015400
Sep 2015400
Oct 2015200
Jan 2016300
Nov 2016200
Dec 2016200
Jan 2017200
Feb 2017200
Mar 2017100
Apr 2017200
May 2017200
Jul 2017200
Oct 2017100
Dec 2017100
Apr 2018100
Sep 2018300
Nov 2018100
Feb 2020400
Mar 20201500
Apr 2020800
May 2020100
Jul 2020300
Aug 20201400
Sep 20202100
Oct 20201300
Nov 20202000
Dec 20201100
Jan 2021300
Feb 20211400
Mar 20211000
Apr 20211100
May 2021600
Jun 2021200
Jul 20211300
Aug 20212800
Sep 20211000
Oct 2021900
Nov 20215500
Dec 20213300
Jan 20225900
Feb 20221900
Mar 20221700
Apr 20222100
May 20222400
Jun 2022300
Jul 2022300
Aug 2022400
Sep 2022100
Oct 2022300
Dec 2022200
Feb 2023100
Mar 2023100
Apr 2023100
May 2023300
Jun 2023400
Jul 2023200
Aug 2023400
Sep 2023200
Oct 2023100
Nov 2023100
Dec 2023200
Jan 2024500
Feb 2024100
Mar 2024500
Apr 2024100
May 2024300
Jun 2024300
Jul 2024300
Aug 20241200
Sep 2024600
Oct 2024200
Nov 2024300
Dec 2024200
Jan 2025100
Mar 2025100
Apr 2025300
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In-vivo proliferation imaging for early response assessment in patients with aggressive non-Hodgkins lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
In-vivo proliferation imaging for early response assessment in patients with aggressive non-Hodgkins lymphoma
Ken Herrmann, Ivan Santi, Ulrich Keller, Tibor Schuster, Martina Rudelius, Hans-Jürgen Wester, Christian Peschel, Markus Schwaiger, Tobias Dechow, Andreas Buck
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 32;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In-vivo proliferation imaging for early response assessment in patients with aggressive non-Hodgkins lymphoma
Ken Herrmann, Ivan Santi, Ulrich Keller, Tibor Schuster, Martina Rudelius, Hans-Jürgen Wester, Christian Peschel, Markus Schwaiger, Tobias Dechow, Andreas Buck
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 32;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy: Special Session

  • Comparison of four different imaging response criteria in patients with Hodgkin and non-Hodgkin lymphoma using PET/CT
  • Regional 213Bi-DOTATOC peptide receptor alpha-therapy in patients with neuroendocrine liver metastases refractory to beta-radiation
  • Imaging prostate cancer PC-3 xenografts pretargeted with bispecific Bombesin-anti-DTPA-Fab′ complexes and targeting with Tc-99m labeled polymers
Show more Oncology: Basic, Translational & Therapy: Special Session

Nuclear Oncology Council Young Investigator Award Symposium

  • Comparison of four different imaging response criteria in patients with Hodgkin and non-Hodgkin lymphoma using PET/CT
  • Regional 213Bi-DOTATOC peptide receptor alpha-therapy in patients with neuroendocrine liver metastases refractory to beta-radiation
  • Imaging prostate cancer PC-3 xenografts pretargeted with bispecific Bombesin-anti-DTPA-Fab′ complexes and targeting with Tc-99m labeled polymers
Show more Nuclear Oncology Council Young Investigator Award Symposium

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire